Linde North America, Inc. 5
5 · Bellerophon Therapeutics, Inc. · Filed Jan 2, 2018
Insider Transaction Report
Form 5
Linde North America, Inc.
10% Owner
Transactions
- Purchase
Common Stock Warrants (right to buy)
2016-11-29+1,920,000→ 1,920,000 totalExercise: $0.80Exp: 2021-11-29→ Common Stock (1,920,000 underlying) - Purchase
Common Stock
2016-11-29+1,920,000→ 5,271,796 total - Purchase
Common Stock Warrants (right to buy)
2017-09-29+1,721,992→ 1,721,992 totalExercise: $1.24Exp: 2022-09-29→ Common Stock (1,721,992 underlying) - Purchase
Common Stock
2017-09-29+1,721,992→ 5,271,796 total
Footnotes (4)
- [F1]The reported securities are included within Units purchased by the reporting person for $0.70 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.
- [F2]The reported securities are included within Units purchased by the reporting person for $1.205 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.
- [F3]The warrants to purchase shares of common stock are currently not exercisable by Linde North America, Inc. due to the exercise limitations of the warrants.
- [F4]The warrants to purchase shares of common stock are currently not exercisable by Linde North America, Inc. due to the exercise limitations of the warrants.